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Values around 100HU were obtained for the PLA, and 
780HU for the silicone from the phantom CT scan. The 
differences between the dose calculated with the TPS 
and measured with ionization chamber were analyzed. 
Plan doses shown differences below 1.5% in all cases. 
Analysing the fields individually, the biggest difference 
was 3.6 % and the average difference was 0.68±1.54%. 
Conclusion  
We can conclude that it is feasible to design and 
construct a 3D printed heterogeneous phantom 
representing patient anatomy. This phantom can be 
routinely used to perform dosimetric checks of advance 
external beam treatment modalities. 
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Purpose or Objective   
Dolphin's new transmission detector and compass DVH-
based analysis program to validate stereotactic plans. 
Material and Methods  
20 lung SBRT and 25 SRS/SRT patients were prepared 
non-coplanar VMAT field plans in the Monaco 5.11 
treatment planning system. Patient QA was measured 
with the Dolphin trasmission detector and evaluated by 
gamma index analysis in the DVH based Compass 4.0.27 
program. In stereotactic plans, treatment is performed 
with a heterogeneous dose distribution in the target 
volume and plans with a high dose gradient outside the 
target. Gamma index values were calculated according to 
the criteria of 3%-3mm, 2%-2mm, 1%-1mm and 3%-1mm as 
dose difference and distance to agreement in QA of 
stereotactic plans. The gamma value of >90% of all points 
evaluated in two dimensions is not sufficient to detect 
plan accuracy in stereotactic treatments. For a more 
detailed analysis, average gamma index values were 
calculated, which was calculated by taking the numerical 
values of the gamma values at each evaluated point into 
account. 
In stereotactic plans there is a rapid dose drop with the 
high dose gradient outside the target. For this reason, 
the target volumes were given 1cm, 2cm, 3cm and 4cm 
margins, and the regions to be analyzed in three 
dimensions were formed. The average gamma index 
values of these regions were calculated. 
Results  
The plans were calculated by Monte Carlo dose 
calculation algorithm in Monaco planning system. Then 
the plans transferred to the compass system were 
recalculated with the Collapse Cone algorithm. Finally, 
the dose obtained with the Dolphin detector was 
transferred to the computed tomography images and 
computed with the collapse cone algorithm. Differences 
between TPS and Dolphin in SRS/SRT plans, PTV1; 5.1%, 
PTVaverage; 8.1% and PTV99; 9.2%. Differences between 
Compass and Dolphin in SRS/SRT plans, PTV1; 2.9%, 
PTVaverage; 4.8% and PTV99; 6.5%. Differences between 
TPS and Dolphin in lung SBRT plans, PTV1; 3.5%, 
PTVaverage; 2.2% and PTV99; 2.6%. Differences between 
Compass and Dolphin in SRS/SRT plans, PTV1; 2.7%, 
PTVaverage; 2% and PTV99; 2.6%. 
When average gamma values are examined in the regions 
formed with 1,2,3,4 cm margins in SRS/SRT/SBRT plans; 
3%-3mm 0.34-0.52, 2%-2mm 0.51-0.75, 1%-1mm 0.92-
1.14, 3%-1mm 0.36-0.81. The most accurate criteria for 
SRS/SRT/SBRT is 2%-2mm and 3%-1mm. In 2D gamma 
analysis, SRS/SRT was 96% and SBRT was 88% according to 
the criteria of %2-2mm. SRS/SRT was 93% and SBRT was 
83% according to the criteria of %3-1mm. 
 
 
Conclusion  
DVH-based analysis is very important in verifying 
stereotactic plans. it is more accurate to analyze 
according to the criteria of 3-1mm and 2-2mm because it 
has high homogeneity and gradient index in stereotactic 
plans.We do a more comprehensive analysis with average 
gamma. 
The main reason for differences between Monaco and 
Compass with dolphin measurement is that the plans 
have high dose gradients and high dose heterogeneity. 
Especially in small volume PTVs these differences are 
increasing. 
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Purpose or Objective  
Vendor-independent Monte Carlo (MC) dose calculation 
(IDC) for patient-specific quality assurance of multi-leaf 
collimator (MLC) based CyberKnife treatments was 
recently developed. This IDC framework is now used to 
benchmark and validate the new vendor-developed MC 
dose calculation engine for MLC based treatments built 
into the CyberKnife treatment planning system (TPS MC). 
Material and Methods  
Both the IDC framework and TPS MC algorithm are 
commissioned using output factor, dose profile and depth 
dose (IDC commissioning) and tissue-phantom ratio (TPR) 
(TPS MC commissioning) measurements of the same 
CyberKnife M6 system. The IDC framework uses the 
EGSnrc MC transport, EGS++ geometry package and 
DOSXYZnrc scoring code, while the TPS MC uses a 
proprietary system. For photon transport in TPS MC, CT 
numbers are converted to either air, soft tissue or bone 
composition with mass density assigned from a CT 
calibration curve included in plan data. Electron and 
positron transport in TPS MC is performed with pre-
simulated tracks in water. In IDC, CT numbers are 
converted to 14 different biological material 
compositions and mass density according to a built-in CT 
calibration curve. The benchmark includes dose profiles 
in water in 15 mm depth and depth dose curves of 11 
rectangular MLC shaped fields ranging from 
7.6 mm x 7.6 mm to 115.0 mm x 100.1 mm, which are 
compared between IDC, TPS MC and measurements in 
terms of dose difference (DD) and distance to agreement 
(DTA). Dose distributions of nine clinical cases (7 lung and 
2 prostate) are calculated using both the IDC framework 
and the TPS MC from CT, plan and structure data. 
Quantitative comparison of these dose distributions is 
performed using dose-volume parameters and 3D gamma 
analysis with 2% global DD and 1 mm distance criteria and 
a global 10% dose threshold. Dose distributions in the TPS 
MC are calculated with a targeted uncertainty of 1% for 
prostate and 2% for lung cases and smoothed with a 
Gaussian kernel. All IDC dose distributions show mean 
statistical uncertainties in voxels with dose higher than 
50% of the dose maximum of 0.6% − 1.3% for all 
treatment plans. 
Results  
Dose profiles in 15 mm depth show agreement between 
TPS MC and IDC to be within about 3% / 1 mm with the 
largest differences found in the shoulder region of the 
two largest field sizes, where the TPS MC calculates 
higher doses than IDC. Depth dose curves agree within 
2.3% / 1 mm with the largest difference found for the 
smallest MLC field size (7.6 mm x 7.7 mm), where IDC 
calculates lower doses than both measurement and the 
TPS. For the nine clinical treatment plans, mean PTV 
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doses differ by an absolute mean of 0.7% between TPS MC 
and IDC (range -1.0% to +2.3%). Lung V20 agrees within 
+/- 1.5% for the lung cases. Gamma passing rates are 
>=97.2% for all cases. 
Conclusion  
TPS MC was successfully benchmarked against an 
independent MC dose calculation framework. 
 
   
EP-1843  Pre-verification of SBRT plans using VMAT 
with 6FFF beams - quantitative and qualitative analysis 
M. Kruszyna1, B. Bajon1, A. Skrobała1, E. Konstanty1 
1Greater Poland Cancer Centre, Medical Physics 
Department, Poznan, Poland 
 
Purpose or Objective  
The SBRT of patients with lung tumor using respiratory-
gated VMAT is an advanced procedure requiring careful 
dose verification. For small fields with MLC HD, FFF 
beams which were used with present of tissues 
heterogeneous in lungs and doses which reach up to 
several greys the verification has become a challenge. 
Commonly used gamma method with standard (3%/3mm) 
criteria could be insufficient. In addition to quantitative 
analysis, an advanced qualitative analysis of the 
comparative dose distribution is required. 
The aim of the work was to determine the optimum 
verification conditions for respiratory-gated SBRT using 
VMAT with 6FFF beams and evaluate the usefulness of 
DVH reconstructed based on measurement (DVH-
measured).  
Material and Methods  
In the first part, the correctness of 3D dose 
reconstruction and DVH-measured (Verisoft 7.1 PTW, 
Freiburg) based on measurement with SRS1000 and 
rotational Octavius phantom was checked for 6FFF VMAT 
(TrueBeam 2.5 with MLC HD) and different open field size 
(2x2-12x12cm2), gantry angle (0, 90, 270, 180), open arc 
field. Next, the measurement and analysis with gamma 
method (DD: G/L3%/2%, DTA: 3mm/2mm with different 
threshold: 5, 50, 90%) were used to verify selected 10 
treatment plans. In addition, using DVHs reconstructed 
based on measurement in comparison to planned DVH, 
individual plans were analyzed for PTV structure (D98, 
D50, D2). All plans were also analysed with Quazar 
motion phantom. 
Results  
For open fields, for different angles of gantry and arcs, 
compliance with the planned values at the gamma level 
(L2%/2mm) of 99.1-100% (SRS) was achieved. For field 
sizes less than 5x5cm, the coefficient due to small fields 
was determined to achieve score results: 97.4-99.5%. For 
phantom with artificial structures, the agreement of the 
DVH-measured parameter with DVH-planned values less 
than 1.5% was obtained. For patients, mean score values 
using gamma evaluation method were achieved, (5, 50, 
90% of TH), respectively:  97.99±0.88%, 94.02±3.53%, 
79.72±14.31% (L2%/2mm), 99.75±0.27%, 98.79±1.44%, 
92.68±6.87% (G3%/3mm). The differences between DVH-
measured for clinical cases and DVH-planned were as 
below, in median: -0.98% (D98), 1.89% (D50), 8.73% 
(D98). 
Conclusion  
The 3D dose reconstruction and DVH-measured with a 
high resolution SRS1000 after appropriate adaptation and 
validation is suitable for pre-verification of SBRT. The 
gamma method is a well-known method, but in advanced 
techniques more rigorous criteria (L2%/ 2mm) also with 
various threshold should be applied. DVH-measured with 
presentation of failed points on patients’ CT scans can be 
used as an additional (qualitative analysis) tool to 
identify clinically-relevant errors. 
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Purpose or Objective  
RapidArc is a fairly new technique in radiation therapy 
delivery. In spite of this, it is widely used for almost 
every type of tumor and location. The need of use of 
intensity modulated radiation therapy with static fields 
or arc is not always justified for all the treatment sites. 
We decided to provide a dosimetrical analysis for the 3 
types of treatment plans that we mentioned earlier. The 
purpose is to give clear guidelines for breast radiation 
therapy in selecting the optimal beam placement and 
type of plan.  
Material and Methods  
We chose 25 patients with treatments delivered to the 
left breast, supraclavicular area, and axilla, all treated 
concomitant. The patient selection was not restricted by 
what type of treatment plan was initially developed. If 
the patient was treated with a 3D conformal plan we 
generated the other type of plans trying to obtain the 
same coverage or better and the same healthy tissue 
sparing or better as the initial plan. We then analyzed 
the dose uniformity, the hot spots in the normal tissue 
and the maximum dose in the planning target volume 
(PTV). Multiple arc placements and length have been 
used as well as multiple beam placement were used for 
RapidArc and IMRT respectively to obtain the best 
dosimetric coverage of the tumor and the best normal 
tissue sparing. The volumes that received 5% dose (V5), 
V10 and the mean dose (Dmean) for the ipsilateral lung 
and contralteral lungs were evaluated for the 3 methods 
of planning. Tumor control probability (TCP) and normal 
tumor complications probability (NTCP) were evaluated 
as well for all 3 methods. 
Results  
Our results do not indicate a superiority of the RapidArc 
over the IMRT. In many cases IMRT can be superior to the 
3D plans but not by a significant difference. We noticed 
that the TCP and NTCP do not indicate an improvement 
when using RapidArc versus IMRT.  
Conclusion  
Although RapidArc is a method of treatment that shortens 
the treatment time, therefore minimizes the time a 
patient spends on the table, we do not see a clear 
advantage of using the arc therapy when treating breast 
with radiation therapy. Yes we minimize the 
uncertainties generated during treatment by possible 
patient movement but the benefits do not exist. On the 
contrary all the treatment plans generated with static 
IMRT are dosimetrically superior to RapidArc. In some 
cases even a 3D plan is superior to an IMRT plan therefore 
superior to arc therapy. 
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Purpose or Objective  
Leksell Gamma Knife plans can often be calculated 
without heterogeneity corrections. The purpose of this 
study is to evaluate the impact on the dose in zones close 
to existent heterogeneities inside the intracranial area, 
comparing experimental results with the calculated dose 
by the planning system, in order to estimate the 
uncertainties to be expected on the delivered dose 
distributions under different scenarios. 
Material and Methods  
A LUCY 3D QA phantom was used for this study. This was 
adapted to fit air cavities, bone and metal inserts inside 
its spherical volume. Radiochromic films and 
